May 29, 2024

Understanding Transcranial Magnetic Stimulation Therapy and Its Role in Treating Depression

Transcranial magnetic stimulation or TMS is a noninvasive procedure that uses magnetic fields to stimulate nerve cells in the brain and treat several psychiatric conditions such as major depressive disorder. In this technique, magnetic coils are placed near the head to induce electric currents in targeted regions of the brain. This electromagnetic induction method allows regulating brain activity and has shown promising results in alleviating depression and other mental health issues. This article aims to provide an in-depth understanding of TMS therapy, how it works, conditions it can treat and the future scope of this innovative treatment modality.

What is Transcranial Magnetic Stimulation?

Transcranial magnetic stimulation or TMS is a noninvasive brain stimulation technique approved by the FDA to treat depression. It uses powerful electromagnetic pulses generated by a device placed near the head. These pulses are able to pass through the scalp and skull to stimulate nerve cells in the brain regions linked to depression like the prefrontal cortex. The magnetic pulses create weak electric currents in these targeted areas modifying neuronal activity and signaling. During the TMS sessions, the magnetic coil is placed on the scalp and pressed firmly against the head while short pulses are delivered. This stimulation modulates the activity of nerve circuits in the brain to relieve depression symptoms.

How does TMS Work?

TMS works based on electromagnetic induction principles. The magnetic pulses emitted by the TMS coil pass harmlessly through scalp and skull tissues to target specific brain regions without the need for surgery. When these pulses pass through nerve cells in the targeted brain areas, they depolarize neurons and cause them to fire. This excitation and inhibition of nerve circuits alters signaling patterns and strength of connections between neurons. Repeated stimulation with TMS is thought to induce neuroplastic changes in the brain regions controlling mood, emotions, and reward pathways. The net effect is normalization of neuronal hyperactivity linked to depression. TMS can increase or decrease cortical excitability depending on the parameters used for stimulation like intensity, frequency etc. This precise targeting and modulation of brain activity underlies its antidepressant effects.

Conditions TMS can Treat

While TMS was first approved to treat major depressive disorder, researchers are exploring its efficacy for other conditions. Studies show it may effectively alleviate symptoms of treatment-resistant depression when antidepressant medications fail to provide relief. TMS is also being evaluated for bipolar depression, post-traumatic stress disorder and schizophrenia. Some trials indicate reduced auditory hallucinations, paranoia and negative symptoms in schizophrenia patients. Further, TMS may help minimize stroke recovery time by exciting neurons in the peri-lesional region near brain injuries. It is also being studied for other neuropsychiatric disorders like OCD, borderline personality disorder, drug addiction, tinnitus and chronic pain. However, more research is still needed regarding therapeutic protocols and long term outcomes of TMS for conditions other than major depression.

TMS Procedure and Treatment Course

A typical TMS procedure involves placing a coil connected to a machine over the scalp region targeted for stimulation. This is usually the left prefrontal cortex for depression. Short magnetic pulses are then delivered through the coil while the patient sits comfortably. The treatment only takes around 30 minutes and is painless with mild scalp discomfort in some cases. The FDA has approved TMS for major depressive disorder to be administered as a series of sessions – typically 10-20 over 4-6 weeks, with treatments given daily or multiple times a week. A full course of therapy usually consists of sessions 3 days a week for 4-6 weeks. The timing, frequency and number of pulses are based on the condition and its severity. Patients can resume normal activities after each session as no sedation or anesthesia is required.

Safety and Side Effects

When administered properly by trained medical professionals, TMS therapy is generally very safe and well-tolerated. Some common mild side effects include headaches, scalp pain or discomfort, and tingling or muscle twitching near the site of stimulation which typically subside after treatment. Rare risks involve seizures which are less than 0.1% even in high risk patients. Operating machines or driving shortly after a session should be avoided until any side effects wear off. While considered low risk, TMS is not recommended for patients with metallic implants, cochlear implants, pacemakers and pregnant women. Long term safety data is still emerging but no serious safety concerns have been identified so far across thousands of patients treated worldwide over the last two decades of clinical use. With appropriate safety screening and monitoring during therapy, TMS offers an excellent safety profile as an alternative to medication.

Future Prospects and Conclusion

While TMS is establishing itself as an effective option for treating depression, further research holds promise to expand its applications. Future refinements of TMS coils, parameters, and protocols hope to increase efficacy across more psychiatric disorders and patient populations. Combining TMS with other modalities like cognitive behavioral therapy or medications aims to provide synergistic effects. Advances in magnetic resonance-guided TMS may allow even more precise targeting of deep brain structures for various neurological and neuropsychiatric conditions. With growing acceptance of its favorable safety-efficacy balance, TMS therapy is poised to transform treatment landscapes. As a noninvasive method for modulating specific brain circuits, it presents immense opportunities for personalized and mechanistic approaches to several mental illnesses. With continuing research, TMS holds great potential to revolutionize neuropsychiatry management in the times to come.

*Note:
1.      Source: Coherent Market Insights, Public sources, Desk research
2.      We have leveraged AI tools to mine information and compile it